Marnaz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marnaz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marnaz Today - Breaking & Trending Today

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Sees Large Decline in Short Interest

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 18,600 shares, a decline of 53.5% from the March 31st total of 40,000 shares. Based on an average daily volume of 588,800 shares, […] ....

Transcode Therapeutics Company Profile , Transcode Therapeutics Inc , Exchange Commission , Sabby Management , Transcode Therapeutics , Get Free Report , Code Therapeutics , Free Report , Transcode Therapeutics Daily , Nasdaq Rnaz ,

TransCode Therapeutics (NASDAQ:RNAZ) Earns Buy Rating from HC Wainwright

TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. TransCode Therapeutics Stock Performance RNAZ stock opened at $0.50 on Tuesday. TransCode Therapeutics has a 52 week low of $0.47 and a 52 […] ....

Renaissance Technologies , Transcode Therapeutics Company Profile , Worth Venture Partners , Sabby Management , Citadel Advisors , Transcode Therapeutics Inc , Transcode Therapeutics , Free Report , Code Therapeutics , Venture Partners , Get Free Report , Transcode Therapeutics Daily , Nasdaq Rnaz , Reiterated Rating , Hc Wainwright ,

HC Wainwright Reiterates Buy Rating for TransCode Therapeutics (NASDAQ:RNAZ)

TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. TransCode Therapeutics Stock Performance Shares of RNAZ traded down $0.01 during trading hours on Wednesday, reaching $0.67. 138,372 shares of the company traded hands, compared to its […] ....

Citadel Advisors , Worth Venture Partners , Sabby Management , Renaissance Technologies , Transcode Therapeutics Inc , Transcode Therapeutics , Get Free Report , Code Therapeutics , Venture Partners , Transcode Therapeutics Daily , Nasdaq Rnaz , Reiterated Rating , Hc Wainwright ,